Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Iradimed Corporation
WARNING LETTER
•Iradimed Corporation•April 16, 2014

Iradimed Corporation – FDA Warning Letter, Apr 16, 2014

Record Details

An FDA inspection of Iradimed Corporation in Winter Park, Florida, from April 7-16, 2014, revealed that the firm's MRI infusion pumps, IV lines, and infusion stands are adulterated under section 501(h) of the Act, as their manufacturing methods and controls do not conform to the Quality System regulation (21 CFR Part 820). Key violations include failures to establish and maintain procedures for device design validation (21 CFR 820.30(g)), documenting design review results (21 CFR 820.30(e)), identifying training needs (21 CFR 820.25(b)), and implementing effective corrective and preventive actions (CAPA) (21 CFR 820.100(a)). The firm's responses to some observations were deemed inadequate or required further verification. Additionally, the Mridium 3860 and 3850 MRI infusion pumps were found to be adulterated and misbranded due to significant software modifications without new 510(k) clearance (21 CFR 807.81(a)(3)(1)). The Mridium 3860+ infusion pump was also adulterated and misbranded for being marketed without any prior clearance or approval. Iradimed Corporation is required to immediately cease commercial distribution of these non-compliant devices and take prompt, comprehensive corrective actions, including addressing systemic problems, within fifteen business days. Failure to comply may result in regulatory actions such as seizure, injunction, civil money penalties, and impact on federal contracts and device approvals.

Company
Iradimed Corporation
Inspection date
April 16, 2014
Product type
Devices
Office
Florida District Office
Person
  • Elizabeth W. Ormond
View Company Profile

ID · f2da1ab3-b4aa-42e3-ae60-cfc1b9c73aaa

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.30(g)21 CFR 820.30(e)21 CFR 820.25(b)21 CFR 820.100(a)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Iradimed Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.